Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CYREN Ltd. (CYRN)
|
Add to portfolio |
|
|
|
| Price: |
$0.32
| | Metrics |
| OS: |
8
|
M
| |
-856
|
% ROE
|
| Market cap: |
$2.58
|
M
| |
|
|
|
Net cash:
|
$4.8
|
M
| |
$0.60
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($20.8)
|
M
| |
|
|
|
EBIT
|
($24.8)
|
M
| |
|
|
| EPS |
($4.66)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 31.2 | 36.4 | 38.4 | 0.1 | 0.8 | 31.0 | 27.8 | 31.9 |
| Revenue growth | -14.3% | -5.2% | 55539.1% | -91.1% | -97.5% | 11.6% | -13.0% | -1.0% |
| Cost of goods sold | 15.3 | 14.8 | 15.6 | 14.5 | 11.9 | 10.0 | 8.3 | 8.1 |
| Gross profit | 15.9 | 21.6 | 22.8 | -14.5 | -11.1 | 20.9 | 19.4 | 23.8 |
| Gross margin | 51.0% | 59.4% | 59.5% | -20972.5% | -1429.4% | 67.6% | 70.0% | 74.6% |
| Sales and marketing | 10.8 | 11.7 | 13.8 | 16.2 | 15.6 | 10.8 | 8.7 | 11.8 |
| Research and development | 17.6 | 16.1 | 15.8 | 16.1 | 9.8 | 8.7 | 8.9 | 11.2 |
| General and administrative | 9.3 | 9.6 | 10.9 | 8.3 | 7.3 | 6.6 | 6.3 | 8.0 |
| EBITA | -18.9 | -12.9 | -13.9 | -15.1 | -10.0 | -6.1 | -2.9 | -4.8 |
| EBITA margin | -60.5% | -35.5% | -36.2% | -21936.2% | -1287.4% | -19.6% | -10.5% | -15.0% |
| Amortization of intangibles | 2.9 | 2.8 | 3.8 | 4.2 | 3.7 | | 1.5 | 1.7 |
| EBIT | -21.8 | -15.7 | -17.7 | -19.3 | -13.8 | -6.1 | -4.5 | -6.5 |
| EBIT margin | -69.9% | -43.3% | -46.0% | -27972.5% | -1768.9% | -19.6% | -16.1% | -20.4% |
| Pre-tax income | -23.2 | -17.4 | -18.1 | -19.6 | -15.7 | -6.2 | -4.7 | -7.2 |
| Income taxes | -0.1 | -0.1 | -0.1 | -0.2 | 0.0 | 0.0 | 0.1 | -0.2 |
| Tax rate | 0.6% | 0.7% | 0.6% | 0.8% | 0.3% | 0.0% | | 2.7% |
| Net income | -23.0 | -17.3 | -18.0 | -19.4 | -15.6 | -6.2 | -4.8 | -7.0 |
| Net margin | -73.9% | -47.4% | -46.9% | -28136.2% | -2011.3% | -20.1% | -17.3% | -22.0% |
| |
| Diluted EPS | ($5.90) | ($5.72) | ($0.33) | ($0.36) | ($0.38) | ($0.16) | ($0.14) | ($0.25) |
| Shares outstanding (diluted) | 3.9 | 3.0 | 55.2 | 53.6 | 40.9 | 39.1 | 34.3 | 28.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|